NMTC · Categories · Form 4

NMTC - SEC Form 4 insider transactions

NeuroOne Medical Technologies Corporation (NMTC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NMTC

• 19d
  SEC Form 4 filed by Mills Jason Richard

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 19d
  SEC Form 4 filed by Mathiesen Jeffrey S

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 19d
  SEC Form 4 filed by Buckman Paul

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 19d
  SEC Form 4 filed by Andrle Edward

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 25d
  SEC Form 4 filed by Christianson Mark

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 25d
  SEC Form 4 filed by Mertens Steve

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 25d
  SEC Form 4 filed by Rosa David A

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 41d
  Business Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 45d
  Business Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 65d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 7,376 shares, decreasing direct ownership by 5% to 153,047 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 65d
  Business Development Director Christianson Mark covered exercise/tax liability with 1,812 shares, decreasing direct ownership by 0.79% to 228,920 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 65d
  CEO and President Rosa David A covered exercise/tax liability with 71,325 shares, decreasing direct ownership by 6% to 1,082,590 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 111d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 160,423 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 111d
  CEO and President Rosa David A increased direct ownership by 0.21% to 1,153,915 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 111d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.11% to 230,732 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 114d
  Director Mills Jason Richard was granted 7,758 shares (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 207d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 161,329 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 207d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.11% to 230,985 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 207d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.21% to 1,156,373 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 229d
  Business Development Director Christianson Mark sold $22,203 worth of shares (30,000 units at $0.74), decreasing direct ownership by 11% to 231,238 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 298d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.10% to 261,238 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 298d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 162,235 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 298d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.21% to 1,158,831 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 305d
  SEC Form 4 filed by Director Mathiesen Jeffrey S

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 305d
  SEC Form 4 filed by Director Buckman Paul

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 305d
  SEC Form 4 filed by Director Andrle Edward

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 325d
  Business Development Director Christianson Mark sold $5,804 worth of shares (10,000 units at $0.58), decreasing direct ownership by 4% to 261,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 327d
  SEC Form 4 filed by General Counsel Johns Emily J.

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 338d
  Business Development Director Christianson Mark sold $5,596 worth of shares (8,981 units at $0.62), decreasing direct ownership by 3% to 271,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 340d
  Business Development Director Christianson Mark sold $7,306 worth of shares (11,019 units at $0.66), decreasing direct ownership by 4% to 280,472 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 370d
  SEC Form 4 filed by Business Development Director Christianson Mark

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 370d
  SEC Form 4 filed by Chief Technology Officer Mertens Steve

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 370d
  SEC Form 4 filed by Chief Operating Officer Volker Christopher

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 370d
  SEC Form 4 filed by Chief Financial Officer Mcclurg Ronald W.

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 370d
  SEC Form 4 filed by CEO and President Rosa David A

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 389d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.55% to 163,141 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 389d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.09% to 291,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 389d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.23% to 1,061,289 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 7,376 shares, decreasing direct ownership by 4% to 164,047 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  Business Development Director Christianson Mark covered exercise/tax liability with 1,812 shares, decreasing direct ownership by 0.62% to 291,744 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  CEO and President Rosa David A covered exercise/tax liability with 71,325 shares, decreasing direct ownership by 6% to 1,063,747 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 431d
  Director Buckman Paul was granted 27,778 shares, increasing direct ownership by 25% to 136,804 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 431d
  Director Andrle Edward was granted 27,778 shares, increasing direct ownership by 43% to 92,003 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 431d
  Director Mathiesen Jeffrey S was granted 27,778 shares, increasing direct ownership by 32% to 114,414 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 446d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 171,423 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 446d
  Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 293,556 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 446d
  CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,135,072 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 478d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 1,158 shares, decreasing direct ownership by 0.67% to 171,675 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 478d
  Business Development Director Christianson Mark covered exercise/tax liability with 343 shares, decreasing direct ownership by 0.12% to 293,646 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 478d
  CEO and President Rosa David A covered exercise/tax liability with 4,697 shares, decreasing direct ownership by 0.41% to 1,137,311 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 509d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 172,833 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 509d
  Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 293,989 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 509d
  CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,142,008 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 541d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 173,085 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 541d
  Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 294,079 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 541d
  CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,144,247 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 571d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 1,158 shares, decreasing direct ownership by 0.66% to 173,337 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 571d
  Business Development Director Christianson Mark covered exercise/tax liability with 343 shares, decreasing direct ownership by 0.12% to 294,169 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 571d
  CEO and President Rosa David A covered exercise/tax liability with 4,697 shares, decreasing direct ownership by 0.41% to 1,146,486 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 599d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.14% to 174,495 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)

Other NMTC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends